LUCD vs USB · rev $4.3M vs P/E 12, rev $28.66B
Lucid Diagnostics Inc (LUCD) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported LUCD revenue for 2024-12-31 was $4.3M. Net income was -$45.5M. Revenue was up 79.0% from 2023-12-31 to 2024-12-31. LUCD currently screens at market cap $123.3M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
LUCD currently screens at market cap $123.3M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the LUCD and USB stock pages for the full models.
Not investment advice.